2022 World TB Day Briefing Series
TB: THE PERSISTENT PANDEMIC,
FORGOTTEN BUT NOT GONE
In collaboration with the Congressional TB Elimination Caucus
In commemoration of World TB Day on March 24th, TB stakeholder organizations, including NTCA, are coming together to host three educational webinars for the staff in Congressional offices. The events will explore the state of TB prevention, diagnosis, and treatment both at home and abroad as well as take a closer look at research efforts to develop innovative diagnostics, vaccines, and treatments needed to tackle this often-forgotten but deadly pandemic.
Thursday, March 24th
The Domestic Response to TB
12:00 p.m. EST


Moderated by:
Shaka Brown, MDR TB Survivor and We Are TB Member
Speakers:
Phil LoBue, MD, CDC Division of TB Elimination Director

Sundari Mase, MD, Stop TB USA Chair and California TB Controllers Association President-Elect

Pete Dupree, MPH, National TB Controllers Association Immediate Past President

Preenie Gill, MDR TB Survivor and We Are TB Member

Jeff Starke, MD, Baylor College of Medicine Professor of Pediatric Infectious Disease Medicine

Aakriti Pandita, MD, TB and COVID-19 Survivor and We Are TB Member
Speakers:
Cheri Vincent, MSPH, USAID TB Chief 

Anand Date, MD, MBBS, CDC Global TB Acting Branch Chief

Linda Mafu, Global Fund Civil Society and Global Advocacy Head

Maurine Murenga, Kenyan Activist and Global Fund Board Member Representing AffectedCommunities

Silvia Chiang, MD, Brown University Assistant Professor and Physician
Friday, March 25th
The Global Response to TB
12:00 p.m. EST

Moderated by:
Aakriti Pandita, MD, TB and COVID-19 Survivor, Infectious Diseases Society of America Member, and We Are TB Member
Monday, March 28th
The Need for TB R&D 
12:00 p.m. EST

Moderated by:
Tina Shah, PharmD, TB Survivor, TB Trials Consortium Community Research Advisors Group Member, and We Are TB Member
Speakers:
Shelly Malhotra, IAVI Executive Director of Global Access

Willo Brock, MSc, FIND Vice President of External Affairs 

Mel Spigelman, MD, TB Alliance President and CEO

Michelle Haas, MD, TB Trials Consortium Advocacy & External Relations Committee Chair

Helen Jenkins, PhD, Boston University Associate Professor and Epidemiologist